Langsung ke konten
Global sound
Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive Daily: FDA Requires Safety Label Update on GLP-1 Receptor Agonist

· 2 mnt

Catatan episode

FDA approves Bayer’s asundexian as the first Factor XIa inhibitor for secondary stroke prevention, the FDA requires a new safety label warning across all GLP-1 receptor agonists for a potential NAION risk, and AstraZeneca acquires Omniose to add a bioconjugation platform to its vaccine pipeline.

Situs: audioboom.com

Live, satu jam terakhir: 9.738 lagu di 4.050 stasiun di 100 negara

Jelajahi dunia lewat radio

Cara lain untuk menjelajah (7)

Dengar sesuatu yang bagus? Simpan, atau langsung buka di Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
The G RadioLanjut mendengarkan